aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Rong Fan(Nanfang Hospital), Jinlin Hou(Nanfang Hospital), George Ν. Dalekos, Junqi Niu(First Hospital of Jilin University), Anuj Gaggar(Gilead Sciences (United States)), Indra Neil Guha(Nottingham University Hospitals NHS Trust), Vithika Suri(Gilead Sciences (United States)), Yongpeng Chen(Nanfang Hospital), Hidenori Toyoda(Ogaki Municipal Hospital), Eleanor Barnes(Oxford Health NHS Foundation Trust), George Papatheodoridis(National and Kapodistrian University of Athens), Jian Sun(Nanfang Hospital), Ramazan Idılman(Ankara University), José Luís Calleja(Hospital Universitario Puerta de Hierro Majadahonda), Sharon Hutchinson(Glasgow Caledonian University), Philip J. Johnson(University of Liverpool), Harry L.A. Janssen(Erasmus MC), Takashi Kumada(Gifu Kyoritsu University), Vana Sypsa(National and Kapodistrian University of Athens), Jianqi Lian(Tang Du Hospital), John F. Flaherty(Gilead Sciences (United States)), Marı́a Buti(Vall d'Hebron Hospital Universitari), Lanjia Lin(Gilead Sciences (United States)), Shuyuan Mo(Gilead Sciences (United States)), Hamish Innes(Glasgow Caledonian University), Xiaoguang Dou(China Medical University), Peter Hayes(Edinburgh Royal Infirmary), Qing Xie(Shanghai Jiao Tong University), William L. Irving(University of Nottingham), Thomas Berg(University Hospital Leipzig), Yuanping Zhou(Nanfang Hospital), Lai Wei(Peking University), Longfeng Zhao(Shanxi Medical University), Zhengang Zhang(Virginia Commonwealth University), Lei Shi(University of Michigan), Xiaoping Tang(Guangzhou Eighth People's Hospital), Satoshi Yasuda(Ogaki Municipal Hospital), Chaonan Zhu, Pietro Lampertico(University of Milan), Stephen T. Barclay(Glasgow Royal Infirmary), Yabing Guo(Nanfang Hospital), Jidong Jia
Cited by 346
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k